Inventor · disambiguated record
Junho Chung
Also filed as: CHUNG JUNHO
26 granted patents·15 pending applications·161 citations·filing 2001–2025
95Inventor score
Files withSEOUL NAT UNIV R&DB FOUNDATION14NEURACLE SCIENCE CO LTD11NAT CANCER CT3HANWHA CHEMICAL CORP2SAMSUNG ELECTRONICS CO LTD2
Top patents by PatentIndex Score
41 records- 0195US11618783B2Anti-FAM19A5 antibodies and uses thereofNEURACLE SCIENCE CO LTD·Filed 2018·Granted Apr 4, 2023·9 cites·19 claims
- 0294US11332521B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 17, 2022·12 cites·20 claims
- 0391US7718174B2Anti-HGF/SF humanized antibodyABXIGN INC·Filed 2007·Granted May 18, 2010·33 cites·3 claims
- 0489US7655417B2VCAM-1 specific monoclonal antibodyHANWHA CHEMICAL CORP·Filed 2007·Granted Feb 2, 2010·31 cites·16 claims
- 0586US8008448B2Cotinine neutralizing antibodyNAT CANCER CT·Filed 2008·Granted Aug 30, 2011·8 cites·4 claims
- 0684US11970532B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Apr 30, 2024·4 cites·15 claims
- 0784US2025236663A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 0883US12492246B2Anti-FAM19A5 antibodies and uses thereofNEURACLE SCIENCE CO LTD·Filed 2023·Granted Dec 9, 2025·0 cites·9 claims
- 0983US7408043B2Neutralizing antibody against HGFNAT CANCER CT·Filed 2004·Granted Aug 5, 2008·27 cites·6 claims
- 1081US11167037B2Antibody drug conjugate platform using bispecific antibodySEOUL NAT UNIV R&DB FOUNDATION·Filed 2017·Granted Nov 9, 2021·2 cites·13 claims
- 1181US6710165B2IgE-dependent histamine-releasing factor-binding peptidesLEE KYUNGLIM·Filed 2001·Granted Mar 23, 2004·25 cites·10 claims
- 1278US12390758B2Method of manufacturing zeolite-carbon composite and method of treating exhaust gasSAMSUNG ELECTRONICS CO LTD·Filed 2022·Granted Aug 19, 2025·0 cites·14 claims
- 1378US12202889B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Granted Jan 21, 2025·0 cites·16 claims
- 1476US9631011B2Gremlin-1 antibodySNU R&DB FOUNDATION·Filed 2013·Granted Apr 25, 2017·6 cites·5 claims
- 1576US2025339806A1Method of manufacturing zeolite-carbon composite and method of treating exhaust gasSAMSUNG ELECTRONICS CO LTD·Filed 2025·Application pending·0 cites
- 1673US2025333491A1Anti-fam19a5 antibodies and uses thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1771US2025353902A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1870US10280215B2Anti-C5 antibodies and methods of treating complement-related diseasesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2014·Granted May 7, 2019·1 cites·13 claims
- 1970US8586033B2Integrin αIIbβ3 specific antibodies and peptidesBARBAS CARLOS F·Filed 2004·Granted Nov 19, 2013·1 cites·10 claims
- 2070US2024360209A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 2169US10947299B2Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus and use for sameSEOUL NAT UNIV R&DB FOUNDATION·Filed 2017·Granted Mar 16, 2021·1 cites·9 claims
- 2268US12485185B2Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2022·Granted Dec 2, 2025·0 cites·8 claims
- 2367US2025018037A1Safety control of switchable chimeric antigen receptor t cells using dose-adjustable adaptorsSEOUL NAT UNIV R&DB FOUNDATION·Filed 2024·Application pending·0 cites
- 2465US12492244B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Dec 9, 2025·0 cites·18 claims
- 2564US11339210B2Anti-C5 antibodies and methods of treating complement-related diseasesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2019·Granted May 24, 2022·0 cites·10 claims
- 2660US2025368731A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 2759US9867886B2Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereofCHUNG JUNHO·Filed 2012·Granted Jan 16, 2018·1 cites·4 claims
- 2858US12415851B2Monoclonal antibodies to ELTD1 and uses thereofOKLAHOMA MED RES FOUND·Filed 2019·Granted Sep 16, 2025·0 cites·12 claims
- 2955US12077599B2Anti-ROS1 antibody and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2018·Granted Sep 3, 2024·0 cites·12 claims
- 3055US2021171611A1Antibody that binds to envelope glycoprotein of sever fever with thrombocytopenia syndrome virus and use for sameSEOUL NAT UNIV R&DB FOUNDATION·Filed 2021·Application pending·0 cites
- 3154US11707486B2Natural killer cell expressing anti-cotinine chimeric antigen receptorKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2019·Granted Jul 25, 2023·0 cites·15 claims
- 3254US2024182563A1Anti-cntn4 antibody and use thereofGENOME & COMPANY·Filed 2022·Application pending·0 cites
- 3353US11478555B2Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2016·Granted Oct 25, 2022·0 cites·10 claims
- 3453US2024082305A1Anti-c4d chimeric antigen receptor regulatory t cells and uses thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2022·Application pending·0 cites
- 3553US2021395346A1Stereotypic neutralizing vh clonotypes against sars-cov-2 rbd in covid-19 patients and the healthy populationSEOUL NAT UNIV R&DB FOUNDATION·Filed 2021·Application pending·0 cites
- 3652US2009023894A1Neutralizing Antibody Against HGFNAT CANCER CT·Filed 2008·Application pending·0 cites
- 3750US12098206B2PDGF receptor antibody and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2019·Granted Sep 24, 2024·0 cites·23 claims
- 3849US2009233358A1Method of Regulating A Phosphorylated Protein-Mediated Intracellular Signal Transduction Using An Antibody Specifically Binding To The Phosphorylated ProteinYOUNG IN FRONTIER CO LTD·Filed 2009·Application pending·0 cites
- 3949US2010172902A1Method for treating a vcam-1 mediated diseaseHANWHA CHEMICAL CORP·Filed 2009·Application pending·0 cites
- 4049US2025264482A1Stereotypic bcr clonotypes in alzheimer's disease patients and use thereofSEOUL NAT UNIV R&DB FOUNDATION·Filed 2025·Application pending·0 cites
- 4139US10457741B2Chicken antibody transformed into cysteine and site-specific conjugation using sameSEOUL NAT UNIV R&DB FOUNDATION·Filed 2014·Granted Oct 29, 2019·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Junho Chung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →